JPY 2585.0
(0.35%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 12.72 Billion JPY | 0.71% |
2022 | 12.63 Billion JPY | 4.47% |
2021 | 12.09 Billion JPY | -8.39% |
2020 | 13.19 Billion JPY | -12.56% |
2019 | 15.09 Billion JPY | -11.21% |
2018 | 17 Billion JPY | 5.05% |
2017 | 16.18 Billion JPY | -17.97% |
2016 | 19.72 Billion JPY | -1.36% |
2015 | 19.99 Billion JPY | 52.8% |
2014 | 13.08 Billion JPY | 10.35% |
2013 | 11.86 Billion JPY | -10.27% |
2012 | 13.21 Billion JPY | -2.05% |
2011 | 13.49 Billion JPY | 12.39% |
2010 | 12 Billion JPY | -26.1% |
2009 | 16.24 Billion JPY | -2.0% |
2008 | 16.57 Billion JPY | 3.92% |
2007 | 15.95 Billion JPY | -6.72% |
2006 | 17.1 Billion JPY | 3.34% |
2005 | 16.55 Billion JPY | -3.51% |
2004 | 17.15 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 14.25 Billion JPY | 12.02% |
2023 Q4 | 12.72 Billion JPY | -10.89% |
2023 Q3 | 14.27 Billion JPY | 4.35% |
2023 FY | 12.72 Billion JPY | 0.71% |
2023 Q2 | 13.68 Billion JPY | 13.24% |
2023 Q1 | 12.08 Billion JPY | -4.35% |
2022 Q1 | 12.78 Billion JPY | 5.69% |
2022 Q4 | 12.63 Billion JPY | 0.49% |
2022 FY | 12.63 Billion JPY | 4.47% |
2022 Q3 | 12.57 Billion JPY | 1.44% |
2022 Q2 | 12.39 Billion JPY | -3.04% |
2021 Q3 | 13.45 Billion JPY | 0.67% |
2021 Q1 | 13.22 Billion JPY | 0.22% |
2021 Q2 | 13.36 Billion JPY | 1.07% |
2021 Q4 | 12.09 Billion JPY | -10.15% |
2021 FY | 12.09 Billion JPY | -8.39% |
2020 Q1 | 14.35 Billion JPY | -4.91% |
2020 Q4 | 13.19 Billion JPY | -10.1% |
2020 FY | 13.19 Billion JPY | -12.56% |
2020 Q3 | 14.68 Billion JPY | 0.07% |
2020 Q2 | 14.67 Billion JPY | 2.22% |
2019 Q4 | 15.09 Billion JPY | -9.16% |
2019 FY | 15.09 Billion JPY | -11.21% |
2019 Q1 | 16.23 Billion JPY | -4.5% |
2019 Q3 | 16.61 Billion JPY | -0.58% |
2019 Q2 | 16.71 Billion JPY | 2.96% |
2018 FY | 17 Billion JPY | 5.05% |
2018 Q1 | 16.23 Billion JPY | 0.31% |
2018 Q2 | 17.56 Billion JPY | 8.22% |
2018 Q3 | 17.58 Billion JPY | 0.07% |
2018 Q4 | 17 Billion JPY | -3.3% |
2017 FY | 16.18 Billion JPY | -17.97% |
2017 Q4 | 16.18 Billion JPY | -4.4% |
2017 Q3 | 16.92 Billion JPY | -0.39% |
2017 Q2 | 16.99 Billion JPY | 11.77% |
2017 Q1 | 15.2 Billion JPY | -22.93% |
2016 Q3 | 15.86 Billion JPY | 2.93% |
2016 Q1 | 15.78 Billion JPY | -21.09% |
2016 Q2 | 15.4 Billion JPY | -2.36% |
2016 FY | 19.72 Billion JPY | -1.36% |
2016 Q4 | 19.72 Billion JPY | 24.37% |
2015 Q2 | 15.35 Billion JPY | 27.91% |
2015 Q3 | 16.04 Billion JPY | 4.5% |
2015 Q4 | 19.99 Billion JPY | 24.62% |
2015 Q1 | 12 Billion JPY | -8.27% |
2015 FY | 19.99 Billion JPY | 52.8% |
2014 Q2 | 12.26 Billion JPY | 9.45% |
2014 Q3 | 12.78 Billion JPY | 4.26% |
2014 FY | 13.08 Billion JPY | 10.35% |
2014 Q1 | 11.2 Billion JPY | -5.51% |
2014 Q4 | 13.08 Billion JPY | 2.35% |
2013 FY | 11.86 Billion JPY | -10.27% |
2013 Q4 | 11.86 Billion JPY | -8.73% |
2013 Q1 | 12.6 Billion JPY | -4.66% |
2013 Q2 | 12.72 Billion JPY | 0.98% |
2013 Q3 | 12.99 Billion JPY | 2.13% |
2012 Q3 | 14.38 Billion JPY | -0.21% |
2012 Q4 | 13.21 Billion JPY | -8.12% |
2012 Q2 | 14.41 Billion JPY | 3.1% |
2012 Q1 | 13.98 Billion JPY | 3.62% |
2012 FY | 13.21 Billion JPY | -2.05% |
2011 Q3 | 14.72 Billion JPY | 2.05% |
2011 FY | 13.49 Billion JPY | 12.39% |
2011 Q1 | 12.22 Billion JPY | 1.85% |
2011 Q2 | 14.42 Billion JPY | 17.98% |
2011 Q4 | 13.49 Billion JPY | -8.34% |
2010 Q3 | 14.2 Billion JPY | -15.36% |
2010 Q1 | 16.65 Billion JPY | 2.54% |
2010 FY | 12 Billion JPY | -26.1% |
2010 Q4 | 12 Billion JPY | -15.48% |
2010 Q2 | 16.78 Billion JPY | 0.74% |
2009 Q3 | 17.78 Billion JPY | 1.63% |
2009 Q4 | 16.24 Billion JPY | -8.65% |
2009 Q2 | 17.49 Billion JPY | 0.0% |
2009 FY | 16.24 Billion JPY | -2.0% |
2008 Q4 | 16.57 Billion JPY | -1.74% |
2008 FY | 16.57 Billion JPY | 3.92% |
2008 Q3 | 16.87 Billion JPY | 0.0% |
2007 FY | 15.95 Billion JPY | -6.72% |
2006 FY | 17.1 Billion JPY | 3.34% |
2005 FY | 16.55 Billion JPY | -3.51% |
2004 FY | 17.15 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 24.682% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.737% |
Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 96.963% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | -9.484% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -12555.055% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -342.967% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -230.442% |
Eisai Co., Ltd. | 206.74 Billion JPY | 93.847% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -2893.412% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -505.81% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -3347.696% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 25.081% |
Tsumura & Co. | 79.69 Billion JPY | 84.036% |
Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -636.653% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -5113.934% |
Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 93.713% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 56.052% |
Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 73.265% |
KYORIN Holdings, Inc. | 20.94 Billion JPY | 39.263% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -233.998% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -45.911% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -21103.333% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -2984.121% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -34.128% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 84.652% |
Cyfuse Biomedical K.K. | 913 Million JPY | -1293.428% |
Toho Holdings Co., Ltd. | 30.24 Billion JPY | 57.935% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -350.29% |